Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Cleveland Diagnostics
company
About
Cleveland Diagnostics is a diagnostics company developing efficacious, affordable diagnostics tests to improve cancer diagnostics.
- Cleveland,Ohio,United States
- 11 - 50
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $5M
- Industries
- Biotechnology,Health Care,Health Diagnostics
- Founded date
- Jan 1, 2013
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Legal Name
- Cleveland Diagnostics, Inc.
Cleveland Diagnostics is a commercial-stage diagnostics company developing efficacious, lab-friendly, affordable diagnostics tests using proprietary technology to improve cancer diagnostics. Its solvent interaction analysis technology investigates protein biomarkers at the structural level, providing better and more direct insights regarding the protein origin on the cellular level, thus improving test specificity to the underlying disease process. Its portfolio of non-invasive cancer diagnostics will be expanding from prostate cancer to breast cancer and lung cancer, and certain neurological diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
6
$35.98M
Cleveland Diagnostics has raised a total of
$35.98M
in funding over 2 rounds. Their latest funding was raised on
Feb 9, 2021 from a Convertable Note round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 9, 2021 | Convertable Note | $2M | — | — | — | Detail |
| Feb 9, 2021 | Series D | $17.40M | 2 |
LYFE Capital
|
— | Detail |
| Nov 28, 2017 | Convertable Note | $2M | 1 |
Genomic Health
|
— | Detail |
| Dec 12, 2016 | Series B | $5M | — | — | — | Detail |
| Jan 18, 2016 | Series C | $7.60M | — | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
2
3
Cleveland Diagnostics is funded by 3 investors.
LYFE Capital
and Genomic Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
LYFE Capital
|
Yes | Series D |
|
Genomic Health
|
Yes | Convertable Note |
Cleveland Clinic
|
— | Series D |
Employee Profiles
Number of Employee Profiles
5
Cleveland Diagnostics has 5 current employee profiles, including
Executive Boris Zaslavsky
Executive
Executive
Executive
Executive
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
